Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Non-cash Items (2022 - 2025)

Historic Non-cash Items for Silence Therapeutics (SLN) over the last 4 years, with Q3 2025 value amounting to $4.0 million.

  • Silence Therapeutics' Non-cash Items changed N/A to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $29.1 million for FY2024, which is 86859.57% up from last year.
  • As of Q3 2025, Silence Therapeutics' Non-cash Items stood at $4.0 million.
  • In the past 5 years, Silence Therapeutics' Non-cash Items registered a high of $29.1 million during Q4 2024, and its lowest value of $2.2 million during Q4 2022.
  • For the 4-year period, Silence Therapeutics' Non-cash Items averaged around $7.6 million, with its median value being $3.6 million (2025).
  • As far as peak fluctuations go, Silence Therapeutics' Non-cash Items soared by 3556.3% in 2023, and later skyrocketed by 86859.57% in 2024.
  • Over the past 4 years, Silence Therapeutics' Non-cash Items (Quarter) stood at $2.2 million in 2022, then soared by 35.56% to $3.0 million in 2023, then skyrocketed by 868.6% to $29.1 million in 2024, then plummeted by 86.31% to $4.0 million in 2025.
  • Its Non-cash Items was $4.0 million in Q3 2025, compared to $3.7 million in Q2 2025 and $3.4 million in Q1 2025.